Latest Breaking News On - Gilead science trodelvy - Page 1 : comparemela.com

AstraZeneca places next ADC bet on in-house pipeline

AstraZeneca places next ADC bet on in-house pipeline
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Japan
Japanese
Eli-lilly
Daiichi-sankyo
David-fredrickson
Merck-co
Bristol-myers-squibb
Astrazeneca
European-society-for-medical-oncology
Fierce-biotech
Big-pharma
European-society

AZ touts lung cancer advances for Tagrisso, ADC

AZ touts lung cancer advances for Tagrisso, ADC
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
British
Suresh-ramalingam
Daiichi-sankyo
Joaquin-duato
Dave-fredrickson
Johnson
National-comprehensive-cancer-network
Astrazeneca
Emory-university
European-society-for-medical-oncology-congress
European-society

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

China
France
United-kingdom
French
British
Chinese
Luke-miels
Keyuan-pharma
Daiichi-sankyo-enhertu
Justin-wang
China-national-reimbursement-drug-list
Pfizer

Fierce Pharma Asia—BMS' $8.4B ADC bet; China's reimbursement update; FDA's CAR-T roadblock

Fierce Pharma Asia—BMS' $8.4B ADC bet; China's reimbursement update; FDA's CAR-T roadblock
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
China
North-carolina
Chinese
Eisai-keytruda-lenvima
Daiichi-sankyo-enhertu
Astrazeneca
National-reimbursement-drug-list
Bristol-myers-squibb
Zai-lab
Big-pharma